Patrick B. Lappin
Impact in
- Rheumatology top 10%
- Systemic Lupus Erythematosus Research
- Bone and Dental Protein Studies
-
- T-cell and B-cell Immunology
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 4
- Oncology 9
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Thomas A. Zanardi (2 shared papers)James G. Christensen (5 shared papers)Brett H. Simmons (4 shared papers)Farbod Shojaei (3 shared papers)Joseph H. Lee (3 shared papers)Wendy Halpern (1 shared paper)John Zhong (1 shared paper)Marta L. Corcoran (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Clinical Cancer Research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Toxicological Sciences (2 papers)Toxicologic Pathology (2 papers)
- Partner nations
- United StatesFrance
In The Last Decade
Patrick B. Lappin
26 papers receiving 656 citations
Peers
Comparison fields: 5 of 90
- Rheumatology 101
- Immunology 137
- Oncology 174
- Cancer Research 92
- Radiology, Nuclear Medicine and Imaging 127
Countries citing papers authored by Patrick B. Lappin
This map shows the geographic impact of Patrick B. Lappin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Lappin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Lappin more than expected).
Fields of papers citing papers by Patrick B. Lappin
This network shows the impact of papers produced by Patrick B. Lappin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Lappin. The network helps show where Patrick B. Lappin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick B. Lappin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 113 | |
| 2 | 2011 | 62 | |
| 3 | 2012 | 53 | |
| 4 | 2012 | 53 | |
| 5 | 2012 | 50 | |
| 6 | 2012 | 44 | |
| 7 | 2013 | 33 | |
| 8 | 2017 | 31 | |
| 9 | 2015 | 29 | |
| 10 | 2014 | 26 | |
| 11 | 2014 | 20 | |
| 12 | 2012 | 19 | |
| 13 | 2005 | 17 | |
| 14 | 2014 | 17 | |
| 15 | 1997 | 17 | |
| 16 | 2011 | 16 | |
| 17 | 1998 | 15 | |
| 18 | 2003 | 13 | |
| 19 | 1994 | 12 | |
| 20 | 1993 | 9 |
About Patrick B. Lappin
Patrick B. Lappin is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Small Animals and Rheumatology, having authored 26 papers that have together received 674 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Cells and Metastasis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Rheumatology (101 citations), Immunology (137 citations), Oncology (174 citations), Cancer Research (92 citations) and Radiology, Nuclear Medicine and Imaging (127 citations). Patrick B. Lappin has collaborated with scholars based in United States and France. Frequent co-authors include Thomas A. Zanardi, James G. Christensen, Brett H. Simmons, Farbod Shojaei, Joseph H. Lee, Wendy Halpern, John Zhong, Marta L. Corcoran, Kevin P. Baker and Wendy Cai. Their work appears in journals such as Toxicology and Applied Pharmacology, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Toxicological Sciences and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.